New Treatment for SIBO and IBS-C—with Dr. Kenneth Brown
RHR: New Treatment for SIBO and IBS-C—with Dr. Kenneth Brown BY Chris Kresser LAST UPDATED ON April 26, 2019 As you know, I treat a lot of patients with gastrointestinal issues. Two of the most challenging conditions to treat are methane-predominant SIBO and constipation-predominant IBS. Join me as I talk with Dr. Kenneth Brown, a practicing physician and clinical researcher who has been specializing in treating these conditions for the past 15 years. We discuss the drawbacks of existing treatments and a new product that Dr. Brown has developed, called Atrantil. In this episode we cover: • 04:26 The problems with current treatments • 08:03 The underlying issues with IBS-C • 11:12 The connection between SIBO and rosacea • 12:25 The drawbacks to Xifaxan/rifaximin • 15:48 How Atrantil works • 21:08 Studies published on Atrantil • 25:36 Clinical pearls for treating with Atrantil ="player-unavailable">
An error occurred.